Q/C Technologies

QCLSNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$7.310 M

$0.89 +13.75%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$11.6M

Loss-making

Shares outstanding

8,189,838

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#14BiomericaBMRA$12.8M
#15VolitionrxVNRX$7.34M
#16Q/C TechnologiesQCLS$7.31M
#17Trinity BiotechTRIB$6.02M
#18Cardio DiagnosticsCDIO$5.68M

What if Q/C Technologies were worth as much as…

Open the what-if tool →

Gold $30.2T

$3,691,645

Per share 4,135,833× higher

Bitcoin $1.74T

$212,660.51

Per share 238,248× higher

Nvidia $5.52T

$673,489.18

Per share 754,525× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Q/C Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.